Our 2026 Annual Event – “Resilience Through Responsibility: What Does Good Corporate Governance Look Like in Uncertain Times”
On October 8th at Riverside Church in New York City, we gathered with our members, friends, sponsors, and colleagues for a fireside chat with corporate governance expert and former SEC Commissioner Allison Herren Lee and Former SEC Policy Director Corey Klemmer to discuss the challenges that corporations face navigating policy and politics in this fraught era.
Following the fireside chat, we honored ICCR’s 2026 Legacy Award Recipients Cathy Rowan, a groundbreaking leader in shareholder engagement with decades of impact, engaging companies on health equity, human rights, and environmental sustainability on behalf of Trinity Health and the Maryknoll Sisters, among others; and Jeff Perkins, long-time ICCR board member and Executive Director of Friends Fiduciary from 2011-2024, where he skillfully represented Quaker values in his shareholder engagement work, especially as they relate to peace and conflict.
ICCR provides institutional investors with multiple opportunities throughout the year to enhance their capacity to engage on ESG issues.
Upcoming ICCR Member Conferences
2027 Spring Conference: The eek of March 16-18 (NYC)
Bi-Annual ICCR Member Conferences
The full ICCR membership convenes two times annually for four days of meetings to learn from subject matter experts on a range of critical ESG concerns, and to share insights on enhancing impact and strategy-setting, all with an eye towards improving corporate performance. These conferences provide a unique forum in which like-minded investors convene and find support for their advocacy initiatives.
The fall meetings culminate in our annual Special Event bringing together thought leaders from the worlds of faith, business, academia and civil society for a thoughtful discussion of the future of our work—followed by an evening of celebration.
Educational Webinars
ICCR also hosts a series of webinars for the general public, including “How Shareholders Can Champion Leading Practices To Drive 1.5°C Policy Action”, “Demystifying Pharmaceutical Innovation and Access for Investors”, and “Building the Vote: Challenges and Opportunities”.